Back
Day Range
$128.28
$132.84
52-Week Range
$107.00
$160.29
Volume
340,778
50D / 200D Avg
$145.75
/
$134.64
Prev Close
$125.36
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 4382.5 | 0.4 |
| P/B | 1.5 | 2.9 |
| ROE % | 0.0 | 3.8 |
| Net Margin % | 0.0 | 3.9 |
| Rev Growth 5Y % | 14.1 | 10.0 |
| D/E | 0.7 | 0.2 |
Key Takeaways
Revenue grew 14.09% annually over 5 years — strong growth
ROE of 0.04% is below average
Generating 91.80M in free cash flow
P/E of 4382.52 — premium valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 20.47%
Cash machine — converts 12541.53% of earnings into free cash flow
Growth
Revenue Growth (5Y)
14.09%
Revenue (1Y)-6.38%
Earnings (1Y)N/A
FCF Growth (3Y)12.50%
Quality
Return on Equity
0.04%
ROIC2.28%
Net Margin0.03%
Op. Margin4.80%
Safety
Debt / Equity
0.66
Current Ratio2.36
Interest Coverage1.01
Valuation
P/E Ratio
4382.52
P/B Ratio1.51
EV/EBITDA40.13
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -6.38% | Revenue Growth (3Y) | -0.65% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 14.09% | Earnings Growth (5Y) | -70.97% |
| Profitability | |||
| Revenue (TTM) | 2.23B | Net Income (TTM) | 732,000.0 |
| ROE | 0.04% | ROA | 0.02% |
| Gross Margin | 36.76% | Operating Margin | 4.80% |
| Net Margin | 0.03% | Free Cash Flow (TTM) | 91.80M |
| ROIC | 2.28% | FCF Growth (3Y) | 12.50% |
| Safety | |||
| Debt / Equity | 0.66 | Current Ratio | 2.36 |
| Interest Coverage | 1.01 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 4382.52 | P/B Ratio | 1.51 |
| P/S Ratio | 1.44 | PEG Ratio | -47.73 |
| EV/EBITDA | 40.13 | Dividend Yield | 0.00% |
| Market Cap | 3.21B | Enterprise Value | 4.29B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2.23B | 2.38B | 2.26B | 2.28B | 1.32B |
| Net Income | 732,000.0 | -117.69M | -29.66M | -74.29M | 103.14M |
| EPS (Diluted) | 0.03 | -4.83 | -1.23 | -3.11 | 4.74 |
| Gross Profit | 819.66M | 824.78M | 739.87M | 697.76M | 491.49M |
| Operating Income | 106.95M | 42.96M | 22.83M | -42.90M | 123.25M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 4.05B | 4.20B | 4.38B | 4.52B | 1.88B |
| Total Liabilities | 1.93B | 2.24B | 2.26B | 2.43B | 264.71M |
| Shareholders' Equity | 2.12B | 1.97B | 2.12B | 2.09B | 1.62B |
| Total Debt | 1.39B | 1.64B | 1.70B | 1.73B | 45.05M |
| Cash & Equivalents | 307.96M | 308.57M | 254.22M | 208.78M | 552.83M |
| Current Assets | 1.18B | 1.44B | 1.22B | 1.24B | 1.03B |
| Current Liabilities | 498.86M | 556.18M | 481.84M | 494.56M | 200.78M |